George Mason University Antonin Scalia Law School

New York Times Recycles Discredited Positions on Government Patent Rights over Pharmaceuticals

superimposed images from a chemistry labBy Sean O’Connor

The New York Times is at it again. A year after its Editorial Board promoted flawed research on government rights to patented drugs as part of a price control plan, the Board floated the idea again, together with misinformation about the Bayh-Dole Act. Read more